搜索临床试验以:21-194
总计6216个结果
-
AllerganMAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan完全的
-
PfizerJANSSEN Alzheimer Immunotherapy Research & Development, LLC完全的
-
Sylentis, S.A.完全的
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)完全的
-
Gynuity Health ProjectsUniversity of Puerto Rico终止
-
Wake Forest University完全的
-
Cellceutix CorporationDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center完全的
-
Beijing Center for Disease Control and PreventionBeijing Minhai Biotechnology Co., Ltd完全的健康 | 狂犬病
-
Shirish GadgeelMerck Sharp & Dohme LLC撤销非小细胞肺癌 | PD-L1基因突变 | 晚期肺癌非小细胞癌
-
Daiichi Pharmaceuticals完全的
-
ETOP IBCSG Partners FoundationAstraZeneca终止NSCLC IV期 | 表皮生长因子受体基因突变新加坡, 瑞典, 大韩民国, 西班牙, 瑞士, 荷兰, 意大利, 波兰
-
Memorial Sloan Kettering Cancer CenterNovartis Pharmaceuticals主动,不招人
-
Memorial Sloan Kettering Cancer CenterEisai Inc.主动,不招人
-
Roche Sequencing SolutionsPerinatal Quality Foundation: Nuchal Translucency Quality Review完全的
-
UCB Korea Co., Ltd.完全的
-
Memorial Sloan Kettering Cancer Center招聘中
-
HIV Vaccine Trials NetworkNational Institute of Allergy and Infectious Diseases (NIAID); AIDS Clinical Trials Group; HIV...招聘中
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI); Roswell Park Cancer Institute; American Lebanese Syrian Associated...招聘中多形性胶质母细胞瘤 | 室管膜瘤 | 髓母细胞瘤 | 间变性星形细胞瘤 | 间变性室管膜瘤 | 间变性少突胶质细胞瘤 | 弥漫性脑桥脑胶质瘤 | 高级别星形细胞瘤 NOS美国, 加拿大
-
Li Zhang, MD招聘中诊断为 ALK 阳性 NSCLC | 第二代 ALK-TKI 耐药 | Ensatinib 在这部分患者中的疗效中国
-
University of WashingtonBill and Melinda Gates Foundation; University of Witwatersrand, South Africa尚未招聘
-
Gynuity Health Projects完全的
-
Scott and White Hospital & ClinicWarner Chilcott完全的
-
Baylor College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)招聘中